Clin2
NCT05981118Possibly a fitEnrolling by invitation

Psoriasis treatment and skin color change study

ICD10 Code L40.9 for Psoriasis

Treatments studied

Part of Skin clinical trials.

This study tests a cream for psoriasis to see if it helps prevent or reduce changes in skin color (dark or light patches) that can happen after psoriasis clears. It may be a good fit if you have medium to dark skin and your psoriasis is stable.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have medium to dark skin (Fitzpatrick skin type 3 or higher).
  • You have been diagnosed with psoriasis (ICD10 code L40.9).
  • Your psoriasis is stable—you've been on the same treatment (like a biologic) for at least 3 months before starting the study.
  • You do not have other skin pigment issues that, in the doctor's opinion, would make it hard to see the results.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07391423Not yet recruiting
Tracking psoriasis treatment with a smartphone

This study looks at how well a common topical treatment (Betamethasone) works for psoriasis. It uses your mobile device to track your progress, so you can participate from home.

Winston-Salem, North Carolina
NCT07635043Not yet recruiting· Phase 4
Tapinarof versus betamethasone cream for plaque psoriasis

This study tests two different creams for plaque psoriasis, a condition that causes scaly patches on the skin. One cream is newer and the other is a standard steroid cream; researchers want to see which one works better and is safer.

Islamabad, Federal
NCT07204639Recruiting· Phase 2
Testing CBP-0276 for moderate to severe psoriasis

This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.

Mexico City
NCT07615712Recruiting
Tracking psoriasis treatment response with a new medication

This study follows people starting a new advanced psoriasis treatment to see how well it works over 16 weeks. You'll have three office visits with your dermatologist, and researchers will track your skin improvement to help understand which treatments work best for different patients.

Waltham, Massachusetts
NCT07725822Recruiting· Phase 4
Cream for psoriasis affecting skin and nails

This study tests a new prescription cream called roflumilast to see if it helps with both skin plaques and nail psoriasis. If you join, you'll apply the cream to affected areas and be monitored to see how well it works and if it's safe.

Dallas, Texas
NCT04036188Recruiting· Early Phase 1
Vitamin D and triamcinolone for plaque psoriasis

This early study tests whether taking vitamin D together with triamcinolone (a steroid used on skin) works better for plaque psoriasis than a standard approach. It aims to see if the combination helps clear psoriasis plaques and is safe.

Fairborn, Ohio

Hear when a new ICD10 Code L40.9 for Psoriasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.